NCT06087211View on ClinicalTrials.gov

Pain Relieving Potentials of Combination of Oral Duloxetine and Intravenous Magnesium Sulphate in Post Mastectomy Pain

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 10, 2023

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
DuloxetineMagnesium SulphatePost-mastectomy Pain Syndrome
Interventions
DRUG

Magnesium sulphate and Duloxetine

Patients received Duloxetine 30mg orally and an intravenous infusion of magnesium sulphate 50mg/kg mixed with 200 ml of normal saline.

DRUG

Duloxetine

Patients received Duloxetine 30mg orally and 200 ml of normal saline.

DRUG

Placebo and normal saline

Patients received a placebo capsule and an intravenous infusion of 200 mL of normal saline.

Trial Locations (1)

11769

National cancer institute, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER

NCT06087211 - Pain Relieving Potentials of Combination of Oral Duloxetine and Intravenous Magnesium Sulphate in Post Mastectomy Pain | Biotech Hunter | Biotech Hunter